Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic SyndromesCristina Astrid Tentori, Olivier Nibourel, Carmen Di Grazia et al.|Journal of Clinical Oncology|2024Cited by 39
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation studyGabriella Morabito, Federico Rea, Giulia Barbati et al.|BMC Public Health|2024Cited by 9
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)Cristina Astrid Tentori, Najla H. Al Ali, Caterina Gregorio et al.|Blood|2023Cited by 5
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and MicrosimulationCaterina Gregorio, Francesca Ieva, Elisabetta Sauta et al.|JCO Clinical Cancer Informatics|2024Cited by 4